People
Kevin Flaherty
Kevin Flaherty is a published external PureTech collaborator and University of Michigan professor. PureTech highlights his work on the Phase III nintedanib trial in progressive fibrosing interstitial lung disease, published in NEJM. No employment or personal investment is inferred.
Roles
PureTech Health
CurrentScientific Collaborator (external; published network)